Clinical Study

Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding

Table 4

Univariate and multivariate logistic analyses of the risk factors for the in-hospital mortality.

Univariate analysisMultivariate analysis
OR95% CI valueOR95% CI value

Hepatitis B virus positivity2.271.30–3.970.0310.380.14–1.080.069
Alcohol0.500.29–0.870.0140.450.19–1.080.075
Hepatocellular carcinoma3.431.92–6.14<0.0018.392.81–25.05<0.001
Hepatic encephalopathy3.641.99–6.66<0.0011.610.69–3.780.273
Bilirubin1.141.09–1.20<0.0011.081.01–1.150.017
Albumin0.320.18–0.54<0.0010.950.42–2.170.907
INR3.022.00–4.55<0.0011.640.94–2.890.08
Creatinine1.831.37–2.44<0.0011.180.90–1.550.229
Initial sodium0.900.86–0.94<0.0010.970.91–1.020.248
MELD score1.151.11–1.20<0.001
Child-Pugh score1.551.36–1.76<0.001
Development of hyponatremia0.130.05–0.32<0.0010.190.07–0.610.005
Shock on admission5.662.92–10.95<0.0011.060.94–1.200.369
Blood transfusion (PRCs)1.101.01–1.190.0281.060.94–1.190.369

INR: international normalized ratio; MELD: Model for End-Stage Liver Disease. PRCs: packed red cells.